Partner Content Partner Content Insightful Developments and an Exclusive Interview from Roch... Ophthalmic Drugs 2018
Partner Content Partner Content San Diego to host Pre-Filled Syringes and Pharmaceutical Mic... Pre-Filled Syringes and Pharmaceutical Microbiology
Partner Content Partner Content Challenges in the development Drug-Device combination produc... Pre-Filled Syringes East Coast 2018 updates
News Andexxa reaches the end of the line in the US AstraZeneca will voluntarily take its anticoagulant reversal agent Andexxa off the market in the US amid reports of serious clotting side effects.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
